Skip to content

Author

L. Szyk-Warszyńska

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Formulation-controlled redaporfin cellular-targeted photodynamic therapy sensitizes tumors to PD-1/PD-L1 blockade via immunogenic cell death.

Redaporfin is a clinically advanced photosensitizer developed for vascular-targeted photodynamic therapy (V-PDT), yet its therapeutic utility under long drug-to-light interval, cellular-targeted PDT (C-PDT), remains limited despite substantial tumor exposure. Here, we show that formulation-dependent control of redaporf...

Marta Warszyńska, L. Szyk-Warszyńska, Dominik Barczyk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.